Anesthetic challenges of patients with cardiac comorbidities undergoing major urologic surgery

International Archives of Medicine

Haki Laho²  Artan Bodeci¹  Myzafer Kaci¹  Arben Beqiri¹  Ilir Ohri³  Hektor Sula³  Rudin Domi³ 

[1] Department of General Surgery, “Mother Teresa” University Hospital Center, Tirana, Albania;Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, USA;Department of Anesthesiology and Intensive Care, “Mother Teresa” University Hospital Center, Tirana, Albania

关键词: Anesthesia;    Urological surgery;    Cardiac patient;   

Others  :  802446
DOI  :  10.1186/1755-7682-7-17

 received in 2013-08-28, accepted in 2014-04-20,  发布年份 2014

【 摘 要 】

The cardiac patient undergoing major urologic surgery is a complex case requiring a great attention by the anesthesiologist. Number of this group of patients having to go through this procedure is constantly increasing, due to prolonged life, increased agressiveness of surgery and increased anesthesia’s safety. The anesthesiologist usually has to deal with several problems of the patient, such as hypertension, chronic heart failure, coronary artery disease, rhythm disturbances, intraoperative hemodymanic changes, intraoperative bleeding, perioperative fluid imbalance, and metabolic disturbances. A cardiac patient undergoing major urologic surgery is a complex case requiring a great attention by the anesthesiologist. The scope of this review article is to present the most frequent issues encountered with this group of patients, and to synthetically discuss the respective strategies and maneuvers during perioperative period, which is the major challenge for the anesthesiologist.

【 授权许可】

   
2014 Domi et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Santulli G: Epidemiology of cardiovascular disease in 21-st century: updated numbers and updated facts. JCvD 2013, 1(1):1-2.
• [2]Santulli G: Coronary heart disease risk factors and mortality. JAMA 2012, 307(11):1137.
• [3]Kheterpal S, O’Really M, Engelsbe M, Rosenberg A, Shanks A, Zhang L, Rothman E, Cambpell D, Tremper K: Preoperative and intraoperative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009, 110:58-66.
• [4]Davenport DL, Ferraris VA, Hosokawa P, Henderson WG, Khuri SF, Mentzer RM Jr: Multivariable predictors of postoperative cardiac adverse events after general and vascular surgery: Results from the patient safety in surgery study. J Am Coll Surg 2007, 204:1199-1210.
• [5]Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, Xavier D, Chrolavicius S, Greenspan L, Pogue J, Pais P, Liu L, Xu S, Malaga G, Avezum A, Chan M, Montori VM, Jacka M, Choi P: Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomised controlled trial. Lancet 2008, 371:1839-1847.
• [6]Fleisher LA, Beckman JA, Brown KA, Calkins H, Chaikof E, Fleischmann KE, Freeman WK, Froehlich JB, Kasper EK, Kersten JR, Riegel B, Robb JF, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Buller CE, Creager MA, Ettinger SM, Faxon DP, Fuster V, Halperin JL, Hiratzka LF, Hunt SA, Lytle BW, Nishimura R, Ornato JP, Page RL, Tarkington LG, Yancy CW, Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery: ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2007, 116:e418-e499.
• [7]Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ, Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L: Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999, 100:1043-1049.
• [8]Boersma E, Kertai MD, Schouten O, Bax JJ, Noordzij P, Steyerberg EW, Schinkel AF, Van Santen M, Simoons ML, Thomson IR, Klein J, Van Urk H, Poldermans D: Perioperative cardiovascular mortality in noncardiac surgery: Validation of the Lee cardiac risk index. Am J Med 2005, 118:1134-1141.
• [9]Fleisher LA, Eagle KA: Clinical practice: Lowering cardiac risk in non cardiac surgery. N Engl J Med 2001, 345(23):1677.
• [10]Lindenauer PK, Pekow P, Wang K, Mamidi DK, Gutierrez B, Benjamin EM: Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005, 353:349-361.
• [11]McFalls EO, Ward HB, Moritz TE, Goldman S, Krupski WC, Littooy F, Pierpont G, Santilli S, Rapp J, Hattler B, Shunk K, Jaenicke C, Thottapurathu L, Ellis N, Reda DJ, Henderson WG: Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004, 351:2795-2804.
• [12]Khuri SF, Henderson WG, Daley J, Jonasson O, Jones RS, Campbell DA Jr, Fink AS, Mentzer RM Jr, Steeger JE: The patient safety in surgery study: Background, study design, and patient populations. J Am Coll Surg 2007, 204:1089-1102.
• [13]Goldhill DR, McNarry AF, Mandersloot G, McGinley A: A physiologically-based early warning score for ward patients: the association between score and outcome. Anaesthesia 2005, 60(6):547-553.
• [14]Goldhill DR, McNarry AF: Physiological abnormalities in early warning scores are related to mortality in adult inpatients. Br J Anaesth 2004, 92(6):882-884.
• [15]Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G: CaMK4 gene deletion induces hypertension. J Am Heart Assoc 2012, 1:e001081.
• [16]Santulli G, Trimarco B, Iaccarino G: G-Protein Coupled Receptor Kinase 2 and Hypertension. High Blood Press Cardiovasc Prev 2013, 20:5-12.
• [17]Lobmeyer MT, Wang L, Zineh I, Turner ST, Gums JG, Chapman AB, Cooper-DeHoff RM, Beitelshees AL, Bailey KR, Boerwinkle E, Pepine CJ, Johnson JA: Polymorphisms in genes coding GRK2 and GRK5 and response differences in antihypertensive treated patients. Pharmacogenet Genomics 2011, 21(1):42-49.
• [18]Fleisher LA, Beckman JA, Brown KA: ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. J Am Coll Cardiol 2007, 50:159-242.
• [19]Nuttall GA, Brown MJ, Stombaugh JW, Michon P, Hathaway M, Lindeen K, Hanson A, Schroeder D, Oliver W, Holmes , David R, Rihal C: Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention. Anesthesiology 2008, 109:588-595.
• [20]Rabbitts JA, Nuttall GA, Brown MJ, Hanson A, Oliver W, Holmes D, Rihal C: Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drugeluting stents. Anesthesiology 2008, 109:596-604.
• [21]UK cancer incidence statistics. 2004. http://info.cancerresearchuk.org/ webcite
• [22]Parekh DJ, Clark T, O’Connor J, Jung C, Chang SS, Cookson M: Orthotopic neobladder following radical cystectomy in patients with high perioperative risk and co-morbid medical conditions. J Urol 2002, 168(6):2454-2456.
• [23]Guazzoni G, Cestari A, Naspro R, Riva M, Centemero A, Zanoni M, Rigatti L, Rigatti P: Intra and Peri-operative outcomes comparing radical retropubic and laparoscopic radical prostatectomy: results from a prospective, randomized, single-surgeon study. Eur Urol 2006, 50(1):98-104.
• [24]Cousins J, Howard J, Borra P: Principles of anaesthesia in urological surgery. BJU Int 2005, 96:223-229.
• [25]Conacher ID, Soomro NA, Rix D: Anaesthesia for laparoscopic urological surgery. Br J Anaesth 2004, 93:859-864.
• [26]Falabella A, Moore-Jeffries E, Sullivan MJ, Nelson R, Lew M: Cardiac function during steep Trendelenburg position and CO2 pneumoperitoneum for roboticassisted prostatectomy: a trans-oesophageal Doppler probe study. Int J Med Robot 2007, 3(4):312-315.
• [27]Takizawa D, Sato E, Ito N, Ogino Y, Hiraoka H, Goto F: Hypoalbuminaemia and propofol pharmacokinetics. Br J Anaesth 2005, 95(4):559.
• [28]Yentis S, Hirsch N, Smith G: Anaesthesia and intensive care A to Z. Butterworth-Heinemann. 2004.
• [29]National Institute for Clinical Excellence: IPG258 Intraoperative red blood cell salvage during radical prostatectomy or radical cystectomy: guidance. 2008. http://www.nice.org.uk/guidance/index.jsp?action¼download&o¼40380 webcite
• [30]Wakeling HG, McFall MR, Jenkins CS, Woods WG, Miles WF, Barclay GR, Flemming S: Intraoperative oesophageal Doppler guided fluid management shortens postoperative hospital stay after major bowel surgery. Br J Anaesth 2005, 95(5):634-642.
• [31]Meiher A, Rolf N, Van Aken H: Thoracic Epidural Anesthesia and the Patient with Heart Disease: Benefits, Risks, and Controversies. Anesth Analg 1997, 85:517-528.
• [32]Nygard E, Kofoed KF, Freiberg J, Søren Holm S, Aldershvile J, Eliasen K, Kelbæk H: Effects of high thoracic epidural analgesia on myocardial blood flow in patients with ischemic heart disease. Circulation 2005, 111:2165-2170.
• [33]Steele SM, Slaughter TF, Greenberg CS, Reves JG: Epidural anesthesia and analgesia: implications for perioperative coagulability. Anesth Analg 1991, 73:683-685.
• [34]Moraca R, Sheldon D, Thirlby R: The Role of Epidural Anesthesia and Analgesia in Surgical Practice. Ann Surg 2003, 238:663-673.
• [35]Werawatganon T, Charuluxanun S: Patient controlled intravenous opioid analgesia versus continous epidural analgesia for pain after intra-abdominal surgery. Cochrane Database Syst Rev 2005, CD004088.